CAPR executive exercises options, sells 24K shares
CAPRICOR THERAPEUTICS, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
CAPRICOR THERAPEUTICS, INC. EVP and General Counsel Karen Krasney exercised stock options to acquire 24,100 shares of common stock at $3.18 per share and sold 24,100 shares in open-market transactions at a weighted average price of $30.38 per share. The sales were made under a pre-arranged Rule 10b5-1 trading plan and occurred in multiple trades between $30.00 and $30.88. Following these transactions, she holds 30,547 shares of common stock and 31,261 stock options directly.
Insider Trade Summary
Exercise and Sale: 24,100 shares ($656K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Krasney Karen
Role
EVP, GENERAL COUNSEL
Sold
24,100 shs ($732K)
Approx. gross sale proceeds
$732K
Approx. exercise cost
$77K
Approx. pre-tax spread
$656K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 24,100 | $0.00 | $0.00 |
| Exercise | Common Stock | 24,100 | $3.18 | $77K |
| Sale | Common Stock | 24,100 | $30.38 | $732K |
Holdings After Transaction:
Stock Option (Right to Buy) — 31,261 contracts (Direct);
Common Stock — 30,547 shares (Direct)
Footnotes (3)
- F1. Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F2. The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.88, inclusive.
- F3. Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Key Figures
Shares sold: 24,100 shares
Weighted average sale price: $30.38 per share
Option exercise price: $3.18 per share
+4 more
7 metrics
Shares sold
24,100 shares
Common stock sold in open-market transactions
Weighted average sale price
$30.38 per share
Open-market sales on June 25, 2026
Option exercise price
$3.18 per share
Stock options exercised for 24,100 shares
Shares held after
30,547 shares
Direct common stock holdings following transactions
Options remaining
31,261 options
Stock options outstanding after partial exercise
Sale price range
$30.00–$30.88
Price range of individual sale trades
Net share change (buy/sell)
-24,100 shares
Net effect of sales versus purchases
Key Terms
Rule 10b5-1 trading plan, weighted average price, Stock Option (Right to Buy), derivative security, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) listed as a derivative security with underlying common stock shares..."
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security for the option exercise entries..."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vesting financial
"Shares vested 1/48th on the first day of each month commencing February 1, 2022."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CAPR executive Karen Krasney report on this Form 4?
Karen Krasney reported exercising options and selling shares of CAPR stock. She exercised 24,100 stock options at $3.18 each, then sold 24,100 common shares in open-market trades at a weighted average price of $30.38 per share on the same date.
Were Karen Krasney’s CAPR stock sales under a Rule 10b5-1 trading plan?
Yes. The Form 4 states the shares were sold pursuant to a Rule 10b5-1 trading plan adopted in December 2025. Such pre-arranged plans automate trading, indicating the timing of these sales was set in advance rather than chosen at the moment.
What stock options did Karen Krasney exercise in the CAPR Form 4 filing?
She exercised 24,100 stock options with a conversion or exercise price of $3.18 per share, receiving the same number of common shares. The options are described as “Stock Option (Right to Buy)” and were scheduled to vest monthly beginning February 1, 2022.
What does the CAPR Form 4 reveal about remaining options for Karen Krasney?
Following the option exercise, 31,261 stock options remain outstanding for Karen Krasney. These options carry an exercise price of $3.18 per share and have an expiration date in January 2032, according to the derivative transaction data disclosed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
